Estrella Immunopharma, Inc. (ESLA)

NCM – Real Time Price. Currency in USD

0.73

+0.03 (4.84%)

Market open: Aug 12, 2026, 12:00 PM EDT

0.76

+0.05 (7.36%)

Previous after-hours: Aug 11, 2026, 7:51 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2022

2021

Total Revenue

Cost of goods sold

Gross Profit

Operating expenses (excl. COGS)

-13M

-9M

-2M

-249K

Operating Income

-13M

-9M

-2M

-249K

Non-operating income, total

654K

Pretax income

-13M

-9M

-915K

-248K

Equity in earnings

Taxes

-838

-126

-81K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-13M

-9M

-996K

-248K

Discontinued operations

Net income

-13M

-9M

-996K

-248K

Dilution adjustment

Preferred dividends

Estrella Immunopharma, Inc. (ESLA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Estrella Immunopharma, Inc. (ESLA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Estrella Immunopharma, Inc. (ESLA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Estrella Immunopharma, Inc. (ESLA)

Income Statement (Annual)

Income Statement (Annual)